Research ELISA (Enzyme-Linked Immunosorbent Assay) - Global Market Trajectory & Analytics

Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market to Reach $571.3 Million by 2027

Amid the COVID-19 crisis, the global market for Research ELISA (Enzyme-Linked Immunosorbent Assay) estimated at US$475.9 Million in the year 2020, is projected to reach a revised size of US$571.3 Million by 2027, growing at a CAGR of 2.6% over the period 2020-2027. ELISA Kits, one of the segments analyzed in the report, is projected to record 2.4% CAGR and reach US$394.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the ELISA Development Sets & Antibody Pairs segment is readjusted to a revised 3.1% CAGR for the next 7-year period.



The U.S. Market is Estimated at $128.7 Million, While China is Forecast to Grow at 5% CAGR

The Research ELISA (Enzyme-Linked Immunosorbent Assay) market in the U.S. is estimated at US$128.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$114.3 Million by the year 2027 trailing a CAGR of 4.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.6% and 2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Select Competitors (Total 113 Featured):

• American Laboratory Products Company (ALPCO) (US)
• BD Biosciences (US)
• BioLegend, Inc. (US)
• Bio-Rad Laboratories, Inc. (US)
• Enzo Life Sciences, Inc. (US)
• Merck KGaA
• Mercodia AB (Sweden)
• R&D Systems, Inc. (US)
• Thermo Fischer Scientific Inc.